Certus Molecular Diagnostics AG
Certus Molecular Diagnostics AG develops rapid and reliable molecular tests for the on-site detection of mycoplasma contamination in cell cultures.
About
Certus Molecular Diagnostics AG provides innovative molecular rapid tests for the on-site detection of mycoplasma contamination, addressing the biotechnology industry’s and R&D laboratories’ need for quick, reliable, and cost-effective quality control solutions. Leveraging extensive expertise in microbiology diagnostics, Certus offers products that deliver laboratory-quality results within 30 minutes with minimal hands-on effort, significantly reducing the risks and costs associated with cell culture contamination. The company is committed to advancing diagnostic standards through customer-focused solutions and custom assay development.
Products & Services
- certus QC – mycoplasma (standard) molecular rapid test kit for cell culture
- certus QC – myco ADVANCED molecular rapid test kit (higher sensitivity, larger sample volume, GMP-like method)
- Custom development of molecular assays for detection of any microbe
- Ready-to-use reagent kits for PCR-based detection of pathogens
Use Cases & Case Studies
- Case study presented at University of Berne
- Exhibition and presentations at scientific and industry conferences (Analytica, BIO-Europe, PharmaLab, ESTIV, EUSAAT, EUROTOX, ToxExpo, Swiss Medtech Day)
Partnerships & Collaborations
- GoldBio (North American distributor)
Awards & Recognition
- Ypsomed Foundation Innovation Prize
- Swiss Medtech 'Start up of the month October 2018'
- Accepted for Innosuisse Core Coaching Phase
- Winner of several entrepreneurial awards and competitions